Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Erik Totté"'
Autor:
Marloes Emous, Merel van den Broek, Ragnhild B Wijma, Loek J M de Heide, Gertjan van Dijk, Anke Laskewitz, Erik Totté, Bruce H R Wolffenbuttel, André P van Beek
Publikováno v:
Endocrine Connections, Vol 8, Iss 7, Pp 969-978 (2019)
Objective: Roux-en-Y gastric bypass (RYGB) is an effective way to induce sustainable weight loss and can be complicated by postprandial hyperinsulinaemic hypoglycaemia (PHH). To study the prevalence and the mechanisms behind the occurrence of hypogly
Externí odkaz:
https://doaj.org/article/a394945eef454efc9504d1ab90715870
Publikováno v:
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, 14(8), 1173-1181. ELSEVIER SCIENCE INC
Background Early and late dumping are side effects of bariatric surgery. Almost no data are available on the prevalence of dumping after different surgical procedures. Objectives Comparison of the relative risks of dumping in a large population of pa
Autor:
Anke Laskewitz, Erik Totté, Marloes Emous, Heide Loek de, Beek Andre van, Albert Wolthuis, den Broek Merel van, Bruce H. R. Wolffenbuttel, Ragnhild B Wijma, Dijk Gertjan van
Publikováno v:
Endocrine Abstracts.
Autor:
Herman J. Woerdenbag, Marloes Emous, Jan A Apers, Bob Wilffert, Eric N. van Roon, Erik Totté, Jacquelien T. M. Wanders, Henderik W. Frijlink, E. Christiaan Boerma, Froukje L Ubels, Blessing Odigie, Jan Peter Yska
Publikováno v:
Eur J Hosp Pharm
European Journal of Hospital Pharmacy: Science and Practice, 27(E1). BMJ PUBLISHING GROUP
European Journal of Hospital Pharmacy: Science and Practice, 27(E1). BMJ PUBLISHING GROUP
Objective Roux-en-Y gastric bypass (RYGB) surgery induces major changes in the gastrointestinal tract that may alter the pharmacokinetics of orally administered drugs. Results from pharmacokinetic studies are sparse. This study aimed to investigate t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90725a0309d4dd863e75cfa00fdacb7d
https://europepmc.org/articles/PMC7147559/
https://europepmc.org/articles/PMC7147559/
Autor:
Bruce H. R. Wolffenbuttel, Erik Totté, Beek Andre van, Marloes Emous, Anneke Muller-Kobold, Anke Laskewitz, Ragnild Wijma, Albert Wolthuis, den Broek Merel van
Publikováno v:
Endocrine Abstracts.
Autor:
Bob Wilffert, Erik Totté, Jan Peter Yska, Albert R. Dreijer, Eric N. van Roon, Marloes Emous, Douwe H. van der Meer, Willeke Eilander, Jan A Apers
Publikováno v:
European Journal of Clinical Pharmacology, 72(2), 203-209. Springer Verlag
PURPOSE: Bariatric surgery can influence the prevalence and incidence of comorbidities, as well as the pharmacokinetics of drugs. This might lead to changes in the use of drugs. This study aimed to assess the influence of bariatric surgery on the use
Publikováno v:
Surgical endoscopy and other interventional techniques, 29(8), 2217-2223. SPRINGER
Several different procedures have been proposed as a revisional procedure for treatment of failed laparoscopic adjustable gastric banding (LAGB). Laparoscopic Roux-en-Y gastric bypass (LRYGB) has been advocated as the procedure of choice for revision
Publikováno v:
Surgical endoscopy. 32(9)
Mini gastric bypass (MGB) is a promising and attractive alternative bariatric procedure. In 2011, we introduced MGB in our high-volume bariatric unit. Subsequently, we evaluated short- and midterm results of this procedure. A prospective cohort of pa
Autor:
van Eric Roon, Bob Wilffert, Henderik W. Frijlink, Jan Peter Yska, Erik Totté, Jan A Apers, Marloes Emous, Herman J. Woerdenbag, R. J. Punter
Publikováno v:
British Journal of Clinical Pharmacology. 78:763-775
Introduction Roux-en-Y gastric bypass (RYGB) surgery is the most commonly performed procedure in bariatric surgery, greatly reducing stomach size and bypassing much of the small intestine. Hence it may reduce the absorption and bioavai-lability of or
Autor:
Jan A. Apers, Bruce H. R. Wolffenbuttel, A. P. van Beek, Marloes Emous, Erik Totté, F. L. Ubels
Publikováno v:
Obesity Surgery. 24:975-1035
Introduction: Worldwide gastric bypass is still the most frequent performed weight loss operations for morbid obesity and it's effectively is proven. Although dumping has been widely recognized as complication after RYGB, almost no data are available